Twist Bioscience (TWST) Other Accumulated Expenses (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Other Accumulated Expenses data on file, last reported at $67.8 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $67.8 million, up 841.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.8 million (up 841.68% YoY), and the FY2025 annual result was $35.2 million, up 505.16% from the prior year.
• Other Accumulated Expenses advanced to $67.8 million in Q1 2026 per TWST's latest filing, from $13.5 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $67.8 million in Q1 2026 and troughed at $5.2 million in Q4 2024.
• A 5-year average of $15.5 million and a median of $10.0 million in 2023 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses slumped 60.47% in 2023, then surged 841.68% in 2026.
• A 5-year view of Other Accumulated Expenses shows it stood at $15.8 million in 2022, then tumbled by 59.44% to $6.4 million in 2023, then slipped by 18.32% to $5.2 million in 2024, then soared by 156.89% to $13.5 million in 2025, then soared by 403.85% to $67.8 million in 2026.
• Business Quant data shows TWST's Other Accumulated Expenses at $67.8 million in Q1 2026, $13.5 million in Q4 2025, and $35.2 million in Q3 2025.